NextPlat Corp. (NASDAQ:NXPL) Short Interest Update

NextPlat Corp. (NASDAQ:NXPL) saw a large drop in short interest in the month of December. As of December 15th, there was short interest totaling 199,110 shares, a drop of 32.5% from the November 30th total of 294,871 shares. Currently, 1.4% of the company’s stock are short sold. Based on an average daily volume of 217,370 shares, the days-to-cover ratio is presently 0.9 days. Based on an average daily volume of 217,370 shares, the days-to-cover ratio is presently 0.9 days. Currently, 1.4% of the company’s stock are short sold.

NextPlat Stock Performance

NextPlat stock traded down $0.04 during midday trading on Monday, reaching $0.55. 229,175 shares of the company traded hands, compared to its average volume of 328,666. The company has a debt-to-equity ratio of 0.04, a current ratio of 3.56 and a quick ratio of 2.80. The firm has a market capitalization of $14.54 million, a price-to-earnings ratio of -1.84 and a beta of 1.16. NextPlat has a 12 month low of $0.43 and a 12 month high of $2.30. The business has a 50 day moving average of $0.69 and a two-hundred day moving average of $0.74.

NextPlat (NASDAQ:NXPL) last issued its quarterly earnings data on Wednesday, November 12th. The company reported ($0.08) earnings per share (EPS) for the quarter. The firm had revenue of $13.75 million for the quarter. NextPlat had a negative return on equity of 34.22% and a negative net margin of 14.58%.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in NextPlat stock. Citadel Advisors LLC purchased a new position in shares of NextPlat Corp. (NASDAQ:NXPL) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 48,176 shares of the company’s stock, valued at approximately $40,000. Citadel Advisors LLC owned about 0.19% of NextPlat as of its most recent SEC filing. Hedge funds and other institutional investors own 1.30% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of NextPlat in a report on Monday, December 22nd. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company currently has a consensus rating of “Sell”.

NextPlat Company Profile

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.